- Conference Article
- 10.1136/lupus-2026-el.15
S10:01 Identification of autoantibody clusters at diagnosis are associated with clinical outcome in systemic lupus erythematosus
- Mar 01, 2026
- Oral Presentations
- S Reppe Moe + 5 more +5
Publications from 2021 to 2026
Showing 10 of 45 papers
S10:01 Identification of autoantibody clusters at diagnosis are associated with clinical outcome in systemic lupus erythematosus
Incidence and treatment strategy for patellar instability in Norway
PurposeTo determine the incidence and treatment strategy for patellar instability in the Norwegian healthcare system.MethodsClinicians from all regional health regions were invited to contribute to the development of a cross‐sectional survey of the current national clinical practices for managing this patient group. A tailored questionnaire was developed to determine how many hospitals in Norway performed patellar stabilization surgery and which surgical procedures and postoperative routines were used. Specifically, the following variables were included: number of procedures performed in 2023, types of procedures, treatment of children, choice of graft for primary MPFL reconstruction, routine use of orthoses and postoperative restrictions.ResultsA survey was conducted among 68 hospitals, of which 35 reported performing patellar stabilisation procedures. The total number of procedures recorded was 532, yielding an incidence rate of 9.6 per 100,000 people. The number of procedures varied significantly among hospitals, with most performing between five and 20. All hospitals conducted medial patellofemoral ligament reconstruction, while 28 included bony procedures, and only seven performed derotational osteotomies. The preferred graft was gracilis (89%), and the most common fixation method on the femur was intrerference screw (60%). Postoperatively, only 20% of hospitals routinely recommended orthoses, primarily after tibial tuberosity osteotomy (86%). Restrictions on knee flexion were advised by 86% of respondents for up to eight weeks, and weight‐bearing restrictions were recommended by all after tibial tuberosity osteotomy.ConclusionsThis study offers an overview of patellar instability incidence and treatment in Norway, revealing significant variability in surgeries, procedures, restrictions, and follow‐up practices. This underscores the need for standardized guidelines and a national registry to improve patient outcomes and care quality. Future research should focus on evaluating long‐term outcomes of various surgical approaches and protocols to inform best practices.Level of EvidenceLevel III.
Read moreCorrection: Vascular ultrasound as a follow-up tool in patients with giant cell arteritis: a prospective observational cohort study
[This corrects the article DOI: 10.3389/fmed.2024.1436707.].
Comparison of Outcomes Between a Fixed-Loop Cortical Suspensory Device and Metal Interference Screw for Femoral Fixation of Bone-Patellar Tendon-Bone Grafts in Anterior Cruciate Ligament Reconstruction: A Scandinavian Registry Study.
Use of a cortical suspensory device (CSD) is an alternative fixation method for bone-patellar tendon-bone (BPTB) in the femur. To the authors' knowledge, no study has compared revision outcomes and patient-reported outcomes (PROs) with the traditional interference screw (IS) fixation. To compare the survival rate of grafts fixated on the femoral side with either a fixed-loop CSD or IS for primary anterior cruciate ligament reconstructions (ACLRs) with BPTB autograft 2 and 5 years after index surgery, as well as to compare PROs between the same 2 treatment groups based on data from 3 National Knee Ligament Registers (NKLRs) in Scandinavia. Cohort study; Level of evidence, 2. The study included patients registered in the NKLRs of Norway, Denmark, and Sweden who underwent primary ACLR from 2005 to 2021. Patients undergoing additional surgery for concomitant injuries to the posterior cruciate ligament, lateral collateral ligament, or medial collateral ligament and patients with major cartilage lesions were excluded. Cox regression models with and without adjustment for possible confounding from age, sex, meniscal and chondral injury, tibial fixation, surgical time, time from injury to surgery, injury mechanism, and country were used to calculate hazard ratios (HRs) and 95% confidence intervals. The possible effects of femoral fixation on 1-year postoperative KOOS QoL and on change from preoperative to 1-year postoperative KOOS QoL were analyzed using multiple linear regression with adjustment from possible confounding from the same variables. P values <.05 were considered significant. A total of 13,955 primary ACLRs met the inclusion criteria during the study period; 1852 patients (13%) had a femoral CSD fixation and 12,103 patients (87%) a femoral IS fixation. No significant difference was observed in overall risk of revision between CSD and IS (HR, 1.10; 95% CI, 0.83 to 1.47; P = .5), and differences in cumulative survival at 2 years (CSD: 98.3% vs IS: 98.6%) and 5 years (CSD: 96.3% vs IS: 96.4%) were not statistically significant. No difference was found for mean KOOS QoL delta (1 year minus baseline) when adjusting for possible confounders (mean difference, -1.60; 95% CI, -3.83 to 0.63; P = .16). Data from the Scandinavian NKLRs showed no difference in the risk of revision and no difference in the KOOS QoL for fixed-loop CSD fixation compared with IS fixation on the femoral side with BPTB grafts in primary ACL reconstruction.
Read moreThe effect of prehabilitation for older patients awaiting total hip replacement. A randomized controlled trial with long-term follow up
BackgroundPrehabilitation involving a planned exercise program before surgery is proposed to improve rehabilitation and postoperative outcomes. However, the current evidence on the efficacy of prehabilitation for patients awaiting total hip replacement is conflicting. The aim of this study was to evaluate efficacy of preoperative exercises and education (AktivA®) for adults 70 years or older awaiting total hip replacement.MethodsIn a two-armed randomized controlled trial we recruited 98 participants aged 70 years or older with a Harris Hip Score less than 60 awaiting elective primary total hip replacement. Participants were recruited at three hospitals in Norway between 2019 and 2022. Participants were randomly assigned to prehabilitation or usual care. The prehabilitation group received a tailored exercise program for 6–12 weeks in addition to patient education. Gait speed, the primary outcome, was measured by the 40 m Fast-Paced Walk Test. Secondary outcomes included performance-based tests (Chair Stand Test, Timed Up & Go Test, 6-Minute Walk Test, Stair Climb Test) and patient-reported outcomes (Hip Disability and Osteoarthritis Outcome Score (HOOS) and EQ-5D). Outcomes were assessed at baseline, post intervention, and further 6 weeks, 3-, 6-, and 12 months post-surgery.ResultsFor the primary outcome gait speed at the primary endpoint (3 months post-surgery), no significant between-group differences were observed. However, post-intervention (before surgery), we found a significant improvement in favor of prehabilitation for both gait speed (0.15 m/s, 95% CI 0.02–0.28) and the HOOS quality of life subscale (11.93, 95% CI 3.38–20.48). No other significant differences were found at any post-surgery follow-up for these outcomes. For other secondary outcomes, there were no between-group differences at any point of assessment. Both groups showed improvement across all outcomes 3–12 months after surgery.ConclusionsThe AktivA®program, used as a prehabilitation intervention during a period of 6–12 weeks before total hip replacement did not improve gait speed or any other post-operative outcomes compared to usual care. Both groups demonstrated significant improvement in gait speed and performed well relative to Western reference values 12 months post-surgery. Thus, replacing painful hip joints through total joint replacement seems to outweigh the efficacy of prehabilitation.Trial registrationClinicalTrials.gov Identifier: NCT03602105—initial release: 06/06/2018.
Read moreReliability of surgeon-reported MRI findings to a national spine register.
Abstract Purpose Spine registries contribute to valuable knowledge and research; however, the data quality has been questioned. MRI findings are crucial for diagnostics and grading of degenerative spinal disorders. We aimed to explore the reliability of surgeon-reported MRI findings in a national spine registry (NORspine). Methods We assessed the reliability of MRI findings from three spine centers. Two spine surgeons re-examined previously surgeon-reported MRI findings for a sample of NORspine patients. We assessed the inter-rater reliability and the reliability between the NORspine registry and each study rater by Cohens kappa (ƙ). Results Two spine surgeons re-assessed preoperative MRI of the lumbar spine for 276 previously enrolled NORspine patients; 92 at each treating center equally distributed by three categories of spinal procedures: removal of disc herniation (LDH), decompression of lumbar spinal stenosis (LSS), and lumbar fusion. The inter-rater reliability varied from fair (0.21) to substantial (0.75) (most reliable for detecting LDH and LSS). The reliability between the NORspine registry and each rater varied from slight (0.13) to substantial (0.75). Highest reliability was found for LDH and LSS (ƙ = 0.72–0.75), while degenerative disc (DDD), foraminal stenosis (FS) and Modic changes had lower reliability (ƙ = 0.27–0.49). Conclusion The reliability for surgeon-reported MRI diagnostics to the NORspine registry varied and was substantial for LDH and LSS, moderate for DDD and FS, and slight or fair for Modic changes.
Read moreLong-Term Outcomes of Arthroscopically Verified Focal Cartilage Lesions in the Knee
Background:Focal cartilage lesions (FCLs) are frequently found during knee arthroscopies and may impair quality of life (QoL) significantly. Several treatment options with good short-term results are available, but the natural history without any treatment is largely unknown. The aim of this study was to evaluate patient-reported outcome measures (PROMs), the need for subsequent cartilage surgery, and the risk of treatment failure 20 years after diagnosis of an FCL in the knee.Methods:Patients undergoing any knee arthroscopy for an FCL between 1999 and 2012 in 6 major Norwegian hospitals were identified. Inclusion criteria were an arthroscopically classified FCL in the knee, patient age of ≥18 years at surgery, and any preoperative PROM. Exclusion criteria were lesions representing knee osteoarthritis or “kissing lesions” at surgery. Demographic data, later knee surgery, and PROMs were collected by questionnaire. Regression models were used to adjust for and evaluate the factors impacting the long-term PROMs and risk factors for treatment failure (defined as knee arthroplasty, osteotomy, or a Knee injury and Osteoarthritis Outcome Score-Quality of Life [KOOS QoL] subscore of <50).Results:Of the 553 eligible patients, 322 evaluated patients (328 knees) were included and analyzed. The mean follow-up was 19.1 years, and the mean age at index FCL surgery was 36.8 years (95% confidence interval [CI], 35.6 to 38.0 years). The patients without knee arthroplasty or osteotomy had significantly better mean PROMs (pain, Lysholm, and KOOS) at the time of final follow-up than preoperatively. At the time of follow-up, 17.7% of the knees had undergone subsequent cartilage surgery. Nearly 50% of the patients had treatment failure, and the main risk factors were a body mass index of ≥25 kg/m2 (odds ratio [OR] for overweight patients, 2.0 [95% CI, 1.1 to 3.6]), >1 FCL (OR, 1.9 [CI, 1.1 to 3.3]), a full-thickness lesion (OR, 2.5 [95% CI, 1.3 to 5.0]), and a lower level of education (OR, 1.8 [95% Cl, 1.1 to 2.8]). Autologous chondrocyte implantation (ACI) was associated with significantly higher KOOS QoL, by 17.5 (95% CI, 3.2 to 31.7) points, and a lower risk of treatment failure compared with no cartilage treatment, microfracture, or mosaicplasty.Conclusions:After a mean follow-up of 19 years, patients with an FCL who did not require a subsequent knee arthroplasty had significantly higher PROM scores than preoperatively. Nonsurgical treatment of FCLs had results equal to those of the surgical FCL treatments except for ACI, which was associated with a better KOOS and lower risk of treatment failure. Full-thickness lesions, >1 FCL, a lower level of education, and a greater BMI were the main risk factors associated with poorer results.Level of Evidence:Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Read moreNorwegian society of rheumatology recommendations on diagnosis and treatment of patients with giant cell arteritis.
To provide clinical guidance to Norwegian Rheumatologists and other clinicians involved in diagnosing and treating patients with giant cell arteritis (GCA). The available evidence in the field was reviewed, and the GCA working group wrote draft guidelines. These guidelines were discussed and revised according to standard procedures within the Norwegian Society of Rheumatology. The European Alliance of Associations for Rheumatology (EULAR) recommendations for imaging and treatment in large vessel vasculitis and the British Society for Rheumatology (BSR) guidelines for diagnostics and treatment in GCA informed the development of the current guidelines. A total of 13 recommendations were developed. Ultrasound is recommended as the primary diagnostic test. In patients with suspected GCA, treatment with high doses of Prednisolone (40-60 mg) should be initiated immediately. For patients with refractory disease or relapse, Methotrexate (MTX) should be used as the first-line adjunctive therapy, followed by tocilizumab (TCZ). Norwegian recommendations for diagnostics and treatment to improve management and outcome in patients with GCA were developed.
Read moreCharacteristics and outcomes of patients who did not respond to a national spine surgery registry.
Abstract Background Loss to follow-up may bias outcome assessments in medical registries. This cohort study aimed to analyze and compare patients who failed to respond with those that responded to the Norwegian spine surgery register (NORspine). Methods We analyzed a cohort of 474 consecutive patients operated for lumbar spinal stenosis at four public hospitals in Norway during a two-year period. These patients reported sociodemographic data, preoperative symptoms, and Oswestry Disability Index (ODI), numerical rating scales (NRS) for back and leg pain to NORspine at baseline and at 3 and 12 months postoperatively. At a median of 50 (36–64) months after surgery, we contacted all patients who did not respond to NORspine after 12 months. Those who responded were termed responsive non-respondents and compared to 12 months respondents. Results 123 (27%) of patients did not respond to NORspine 12 months after surgery, and 64 (52%) of those responded to our renewed survey at a median of 50 (36–64) months after surgery. At baseline, non-respondents were younger 63 (SD 11.7) vs 68 (SD 9.9) years, mean difference (95% CI) 4.7 years (2.6 to 6.7); p = < 0.001. Non-respondents were more frequently smokers 41 (30%) vs 70 (21%) RR (95%CI) = 1.40 (1.01 to 1.95); p = 0.044. There were no other relevant differences in other sociodemographic variables or preoperative symptoms. We found no differences in effect of surgery on non-respondents vs respondents (ODI (SD) = 28.2 (19.9) vs 25.2 (18.9), MD (95%CI) = 3.0 ( -2.1 to 8.1); p = 0.250. Conclusion We found that 27% of patients did not respond to NORspine 12 months after surgery for lumbar spinal stenosis. Non-respondents were somewhat younger and more frequently smokers. However, responsive non-respondents reported similar clinical outcomes compared to those who responded.
Read moreThe Phenotype of Mixed Connective Tissue Disease Patients Having Associated Interstitial Lung Disease